Christopher Mikson is a partner in Washington DC, where he serves as leader of Mayer Brown’s FDA Regulatory practice and co-leader of the Health Care practice. With his unique combination of training and experience as a physician, registered patent attorney, and trial lawyer.
He focuses his practice on FDA regulatory matters and complex litigation and transactional matters involving health care and the life sciences. LMG Life Sciences recognized Chris as a “Life Sciences Star” in 2018.
Litigation and Transactional – Chris has comprehensive experience in a broad range of complex litigation matters. He has represented some of the world’s largest pharmaceutical, medical device, consumer product, and technology companies in patent infringement, trade secret, false advertising, and product liability litigation throughout the country.
Chris focuses his litigation practice on FDA regulatory disputes and cases where FDA regulation intersects with other areas of the law such as product liability and intellectual property, including Hatch-Waxman and biosimilar cases.
He is currently defending the publisher of a drug compendium in a Lanham Act case in federal court involving the listing of certain unapproved drugs currently legal for sale based on FDA’s Drug Efficacy Study Implementation (DESI) program.
In addition to his litigation practice, Chris regularly performs transactional work related to FDA-regulated products, including material and service contracts, licensing agreements, and due diligence of major deals.
Chris has long served as a pro bono lawyer with the Support Center for Child Advocates, providing legal representation and social service advocacy for abused and neglected children in his adopted home town of Philadelphia.
- Jefferson Medical College, MD
- University of Pennsylvania
- Rutgers School of Law – Camden, JD
- Rutgers College, BA
- District of Columbia
- New Jersey
- US Court of Appeals for the Federal Circuit
- US Court of Appeals for the Third Circuit
- US District Court for the District of New Jersey
Rate : $$$